Showing results (1-10 of 508) with videos related to

Sort By:
Pageof 51
Current Cardiology Reports|September 14, 2018
Is There Still a Role for Digoxin in the Management of Atrial Fibrillation?Jeffrey B Washam, Manesh R Patel
The American Journal of Cardiology|April 12, 2005
Safety and effectiveness of transdermal nicotine patch in smokers admitted with acute coronary syndromesTrip J Meine, Manesh R Patel, Jeffrey B Washam, et al.
Circulation. Cardiovascular Interventions|February 13, 2018
Anticoagulant Use Among Patients With End-Stage Renal Disease Undergoing Percutaneous Coronary Intervention: An Analysis From the National Cardiovascular Data RegistryJeffrey B Washam, Lisa A Kaltenbach, Daniel M Wojdyla, et al.
Trends in Cardiovascular Medicine|July 29, 2017
Appropriate dosing of nonvitamin K antagonist oral anticoagulants for stroke prevention in atrial fibrillationBenjamin A Steinberg, Jeffrey B Washam
Advances in Chronic Kidney Disease|September 23, 2008
Risks and benefits of antiplatelet therapy in uremic patientsJeffrey B Washam, George L Adams
Journal of Thrombosis and Thrombolysis|October 27, 2015
Why develop antidotes and reversal agents for non-vitamin K oral anticoagulants?Jeffrey B Washam, Jonathan P Piccini
Therapeutic Advances in Cardiovascular Disease|August 25, 2016
Primary and key secondary results from the ROCKET AF trial, and their implications on clinical practiceRohan Shah, Manesh R Patel
Journal of Thrombosis and Thrombolysis|January 25, 2012
Evaluation of dose requirements for prolonged bivalirudin administration in patients with renal insufficiency and suspected heparin-induced thrombocytopeniaJames W Wisler, Jeffrey B Washam, Richard C Becker
Neurosurgery Clinics of North America|September 19, 2018
Anticoagulants: Pharmacokinetics, Mechanisms of Action, and IndicationsTracy A DeWald, Jeffrey B Washam, Richard C Becker
Pageof 51